Market Tracker

08/18 5:16pm ET

Biogen Inc (NASDAQ:BIIB)

281.77
Delayed Data
As of Aug 18
 -2.65 / -0.93%
Today’s Change
244.28
Today|||52-Week Range
303.81
+7.87%
Year-to-Date

Today’s Trading

Previous close284.42
Today’s open283.31
Day’s range281.65 - 285.67
Volume814,072
Average volume (3 months)1,459,887
Market cap$59.6B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+5.78%
Earnings growth (next 5 years)+6.60%
Revenue growth (last year)+9.37%
P/E ratio18.5
Price/Sales6.09
Price/Book5.01

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-1.88-0.98%
GILDGilead Sciences-0.23-0.32%
KITEKite Pharma Inc+4.15+3.29%
BIVVBioverativ Inc+0.04+0.07%
Data as of 4:29pm ET, 08/18/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$5.62
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Senior Vice President-
US Therapeutic Operations
Alisha A. Alaimo
Corporate headquarters
Cambridge, Massachusetts

Forecasts